Identifying Tipping Points during Healthy Brain Aging through Single-Nucleus Transcriptomic Analysis.
Abstract
Brain aging significantly impairs cognitive and behavioral functions. While some nonlinear aging studies have identified age-specific aging peaks at certain ages, the influence of different cell types on brain aging fluctuations across the lifespan remains unclear. This study, approaching from the interdisciplinary perspective of brain aging and systems dynamics, extends the nonlinear aging analysis to the cellular level, using single-cell transcriptomic data to analyze 45 healthy elderly brain samples aged 29-94 years. Describing cellular and molecular differences in the aging process, neuron proportion is downregulated but relatively stable with low variability after aging, while glial cells are significantly upregulated and highly unstable. Notably, peaks in nonlinear molecular fluctuations are observed in aging at ages 60, 70, and 79. The nonlinear features prompted the introduction of a dynamic network biomarker and the identification of 56-60 years as the tipping point in the brain's healthy aging process, then suggesting that glia predominantly mediate this process and exploring the underlying features and mechanisms. This work investigates the tipping point of aging at single-cell resolution and provides new research strategies for early diagnosis and intervention of aging-related neurological diseases.
The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.
Research summary
The paper identifies a tipping point in the brain's healthy aging process at ages 56-60, suggesting that glial cells mediate this process. This research addresses cellular mechanisms of aging, which is crucial for understanding and potentially intervening in the aging process itself.
Author of this paper? Send a correction.